Cahenzli, Julia

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2021 | 2015 | 2014 | 2013 | 2012

2021

Bravo, Francisco; Macpherson, Jamie A; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; McCoy, Kathy D.; Macpherson, Andrew J.; Juillerat, Pascal (2021). Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up. Clinical and translational gastroenterology, 12(2), e00298. Wolters Kluwer Health 10.14309/ctg.0000000000000298

2015

Juillerat, Pascal; Peter, M; Macpherson, James; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (February 2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data (Unpublished). In: European Crohn’s and colitis organization congress (ECCO). Barcelona. Februar 2015.

Juillerat, Pascal; Andrew, Peter; Macpherson, James; Slack, Emma; Seibold, Frank Werner; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data. Gastroenterology, 148(4), pp. 850-1. Elsevier

2014

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, J; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (February 2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives (DOP060). Journal of Crohn's & Colitis, 8(Suppl1), pp. 43-44. Elsevier 10.1016/S1873-9946(14)60085-4

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United european gastroenterology journal, 2(1suppl), A45-A46. Sage

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer Ärzteverlag

2013

Cahenzli, Julia (April 2013). Neonatal bacterial colonisation imprints long-term Immunoglobulin E levels (Unpublished). In: Annual Meeting of the SSAI and SSP. Bern Switzerland. April 2013.

Cahenzli, Julia; Köller, Yasmin; Wyss, Madeleine; Geuking, Markus; McCoy, Kathleen (2013). Intestinal Microbial Diversity during Early-Life Colonization Shapes Long-Term IgE Levels. Cell host & microbe, 14(5), pp. 559-570. Cell Press 10.1016/j.chom.2013.10.004

2012

Kwong Chung, Cheong KC; Cahenzli, Julia; Macpherson, Andrew J.; McCoy, Kathy D.; Geuking., Markus (2012). Compensatory immune mechanisms ensure mucosal immune homeostasis following colonization with commensal bacteria. In: Cross Talk Symposium Paris 2nd to 4th September.

Cahenzli, Julia; Balmer, Maria Luisa; McCoy, Kathleen (2012). Microbial-immune cross-talk and regulation of the immune system. Immunology, 138(1), pp. 12-22. Wiley-Blackwell 10.1111/j.1365-2567.2012.03624.x

Provide Feedback